SCHEMBL24946009

SCHEMBL24946009

CC(C)n1cnc2c(NP)ncnc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 13/20 0.59
CCNB1 P14635 12/20 0.59
CCNB2 O95067 11/20 0.59
CCNB3 Q8WWL7 11/20 0.59
ADORA2A P29274 2/20 0.58
ADORA2B P29275 2/20 0.58
ADORA1 P30542 2/20 0.58
PI4KA P42356 1/20 0.58
PI4K2B Q8TCG2 1/20 0.58
PI4K2A Q9BTU6 1/20 0.58
PI4KB Q9UBF8 1/20 0.58
CDK2 P24941 6/20 0.58
MAPK1 P28482 1/20 0.48
MAPK8 P45983 1/20 0.48
CSNK1A1 P48729 1/20 0.48
CSNK1D P48730 1/20 0.48
CDK7 P50613 1/20 0.48
CCNH P51946 1/20 0.48
MNAT1 P51948 1/20 0.48
CCNA2 P20248 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL756298 0.85 YTHDC1 (0.62) CDK1CCNB1CCNB2CCNB3ADORA2A
SCHEMBL26936162 0.83 CDK1 (0.59) CDK1CCNB1CCNB2CCNB3ADORA2A
SCHEMBL31088354 0.83 ADORA2A (0.63) CDK1CCNB1CCNB2CCNB3ADORA2A
SCHEMBL26354422 0.83 CDK1 (0.69) CDK1CCNB1CCNB2CCNB3ADORA2A
SCHEMBL26199920 0.81 CDK1 (0.57) CDK1CCNB1CCNB2CCNB3ADORA2A
SCHEMBL26354839 0.81 CDK1 (0.72) CDK1CCNB1CCNB2CCNB3ADORA2A
SCHEMBL16707340 0.80 CDK1 (0.67) CDK1CCNB1CCNB2CCNB3ADORA2A
SCHEMBL13057364 0.78 ADORA1 (0.59) CDK1CCNB1CCNB2CCNB3ADORA2A
SCHEMBL19864855 0.78 CDK1 (0.60) CDK1CCNB1CCNB2CCNB3ADORA2A
SCHEMBL21011224 0.78 CDK1 (0.60) CDK1CCNB1CCNB2CCNB3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230022212-A1 METHOD FOR PRODUCING GLYCOSIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230022212-A1 METHOD FOR PRODUCING GLYCOSIDE COMPOUND DHPS, IMPDH1, B3GNT2 CDK1 2084/4885CCNB1 1665/4885CCNB2 2546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.